Curriculum Vitae



Kara Duncan Weatherman, Pharm.D., BCNP, FAPhA

WORK ADDRESS

Purdue University – Department of Pharmacy Practice

601 Stadium Mall Drive – PUSH 332

West Lafayette, Indiana 47907

(765) 496-1815

kdwman@purdue.edu

EDUCATION Doctor of Pharmacy; Purdue University West Lafayette, IN 47907

Conferred: May 1994

LICENSURE Indiana

License Number: #26019680A

CERTIFICATION Board Certified Nuclear Pharmacist: 1996

Recertification by exam: 2003, 2010, 2017

PROFESSIONAL EXPERIENCE AND APPOINTMENTS

2013 to present: Clinical Associate Professor – Department of Pharmacy Practice

Purdue University College of Pharmacy

West Lafayette, Indiana

2011 to 2016: Adjunct Assistant Professor – Department of Pharmaceutical Sciences

University of Tennessee College of Pharmacy

Memphis, Tennessee

2010 to 2013: Clinical Assistant Professor – Department of Pharmacy Practice

Purdue University College of Pharmacy

West Lafayette, Indiana

2008 to present: Adjunct Assistant Professor – Department of Radiologic Sciences

Indiana University School of Medicine – Department of Radiology

Indianapolis, Indiana

2007 to present: Director – Nuclear Pharmacy Programs

Purdue University College of Pharmacy

West Lafayette, Indiana

2006 to 2009: Assistant Professor of Nuclear Pharmacy

Purdue University School of Pharmacy

West Lafayette, Indiana

2000 to 2005: Director – Nuclear Pharmacy Certificate Programs

Division of Nuclear Pharmacy, Purdue University

West Lafayette, Indiana

1998 to 2000: Adjunct Assistant Professor / University Liaison

Division of Nuclear Pharmacy, Purdue University / Syncor International

West Lafayette, Indiana

1995 to 1999: Adjunct Assistant Professor

Department of Pharmaceutical Science University of Tennessee

Memphis, Tennessee

1995 to 1998: Clinical Consultant / Staff Pharmacist

Syncor International Corporation

Chicago, Illinois

1994 to 1995: Assistant Director / Staff Pharmacist

Pyramid Diagnostic Services

Memphis, TN

PROFESSIONAL MEMBERSHIPS

American Association of Colleges of Pharmacy (AACP)

American Pharmacists Association (APhA)

Society of Nuclear Medicine (SNM)

Society for Simulation in Healthcare (IMSH)

STATE RECOGNITION

2013 to present Sterile compounding regulations revision committee – Indiana Board of Pharmacy

2012 to present Nuclear pharmacy consultant – Indiana Board of Pharmacy

NATIONAL RECOGNITION

2018 Subject Expert – Nuclear Pharmacy Role Delineation Committee

Board of Pharmaceutical Specialties

2017 to present Board Member – Joint Review Committee on Educational Programs in Nuclear Medicine Technology (JRCNMT)

2017 Invited Member – United States Food and Drug Administration Stakeholder Listening Session

2017 Invited Panel Member – United States Pharmacopeial Convention Radiopharmaceutical Information Session

2016 to present Member – Society of Nuclear Medicine and Molecular Imaging Committee on Radiopharmaceuticals

2016 to present Member – Society of Nuclear Medicine and Molecular Imaging Qualified Persons Task Force

2016 - 2020 Member – United States Pharmacopeial Convention Radioactive Drug Expert Panel

2016 – 2023 CE Provider – Board of Pharmacy Specialties, Nuclear Pharmacy BPS Recertification Designation

2015 Member – Board of Pharmacy Specialties Role Delineation Committee – Sterile Product Board

2015 Reviewer – National Science Foundation SBIR/STTR program

2012 to 2014 Expert contributor – Revision of United States Pharmacopeia Chapter , Radiopharmaceuticals as Compounded Sterile Products subsection

2010 to present Reviewer – American Journal of Health System Pharmacy

2008 to present Member – Professional Affairs Committee – Nuclear Pharmacy Practice Section

American Pharmacists Association

2008 to 2009 Member – Regulatory Affairs Committee – Nuclear Pharmacy Practice Section

American Pharmacists Association

2006 to present Member – Educational Committee – Nuclear Pharmacy Practice Section

American Pharmacists Association

2006 to 2010 Poster Judge

American Pharmacists Association Annual Meeting

2006 Subject Expert – Nuclear Pharmacy Role Delineation Committee

Board of Pharmaceutical Specialties

2006 Fellow Status

American Pharmacists Association

2004 to 2010 Annual Meeting Abstract Reviewer

American Pharmacists Association

2004 to 2005 Coordinator - Nuclear Pharmacy Educational Sessions for American Pharmacists Association Annual Meeting (15 hours per year)

American Pharmacists Association

2003 to 2005 Member-At-Large, Nuclear Pharmacy Section

American Pharmacists Association

2001 Abstract reviewer

Society of Nuclear Medicine

INTERNATIONAL RECOGNITION

2010 Consultant: Brazilian Radiopharmacist Consortium Nuclear Pharmacy Curriculum Unification Project

2006 – 2011 World Congress Educational Planning committee: International Pharmacy

Federation Nuclear Pharmacy Special Interest Group

2002 – 2005 Co-founder - VirRAD: Virtual Learning Community in Radiopharmacy

TEACHING RESPONSIBILITIES

Purdue University College of Pharmacy

NUPH 49100: Introduction to Nuclear Pharmacy: 1 credit

Faculty (2000 – present)

Course coordinator (2011 – present)

NUPH 49200: Basics of Nuclear Pharmacy: 1 credit

Faculty (2000 – present)

Course coordinator (2012 – present)

NUPH 49300: Regulatory Considerations for Nuclear Pharmacy Practice: 2 credits

Course coordinator (2012 – present)

NUPH 49400: Clinical Aspects of Nuclear Pharmacy Practice: 2 credits

Course coordinator (2012 – present)

NUPH 49500: Applied Nuclear Pharmacy: 2 credits

Faculty (2000 – present)

Course coordinator (2005 – present)

NUPH 49000: Special Projects in Nuclear Pharmacy

Participating faculty (2000 – 2005)

Course coordinator (2005 to present)

CLPH 895: Academic / Research Clerkship (4 week rotation)

Course coordinator (2005 to present)

CLPH 895 (London): International Clerkship in Nuclear Medicine – London

Rotation coordinator (2007 – present)

Indiana University School of Medicine – Nuclear Medicine Technology Program

RADI-R423 Nuclear Medicine In-service I

Participating faculty (2008 to present)

RADI-R424 Nuclear Medicine In-service II

Participating faculty (2008 to present)

RADI-R425: Nuclear Medicine In-service III

Participating faculty (2008 to present)

RADI-R427: Radiopharmaceuticals

Course coordinator (2008 to present)

RADI-R433: Applications of Radionuclides II

Participating faculty (2009 to present)

UNIVERSITY COMMITTEE APPOINTMENTS

Purdue University

2017 – present Digital Education Community Collaboration

2010 – present University Radiation Safety Committee

2006 – 2009 Instructional Technology Advisory Committee

School of Pharmacy, Nursing and Health Sciences representative

2006 – 2009 Computer 2020 Initiative

School of Pharmacy, Nursing and Health Sciences representative

Indiana University School of Medicine

2010 – present Radioactive Drug Research Committee (RDRC)

2010 – present Radionuclide Radiation Safety Committee (RRSC)

COLLEGE OF PHARMACY APPOINTMENTS

2017 – present Strategic Area Task Force – Student Experience & Success

2017 – present Global Program Committee

2016 – present Pharm.D. Academic Standards and Readmissions Committee

2016 – 2017 PHPR IT Committee

2015 – 2016 Common Hour Committee

2014 – present Pharm.D. Academic Standards and Readmission Committee

2011 Skills Lab 2 Task Force

2011 Teaching Innovation Award Development Committee

2011 Continuing Education Director Search Committee

2010 - 2011 Instructional Innovation Committee

2009 - 2010 Diagnosis, Labs and Monitoring Task Force

2008 – 2009 Instructional Educational Technology Assessment Task Force

2008 – 2009 PharmD. Curriculum Review Task Force

2007 – 2008 Technical Standards Task Force

2007 Assistant Dean for Assessment Search Committee

2004 – present Introductory Pharmacy Practice Experience Committee

GRANT SUPPORT: INTERNAL

2018: Instructional Innovation Program

“Development of an Equipment Specific Competency Training Virtual/Augmented Reality (VR/AR) System with Advanced Hand Motion”

Purdue Univeristy Office of Provost

(PI with George Takahashi, Mark Sharp)

$100,000

2017: Study Abroad and Intercultural Learning Grant (SAIL)

Purdue University International Programs

(co-PI with Ellen Schellhase)

$12,000

2017: Instructional Innovation Program

“Student Learning Using HoloLens-based Mixed Reality Instructional Simulations”

Purdue University Office of Provost

(co-PI with Eric Barker, George Takahashi, Mark Sharp)

$98,528

2016: Gloria Niemeyer Francke Pharmacy Practice Advancement Grant

Department of Pharmacy Practice, College of Pharmacy, Purdue University

(co-PI with Ellen Schellhase)

$7,500

2016: Study Abroad and Intercultural Learning Grant (SAIL)

Purdue University International Programs

(co-PI with Ellen Schellhase)

$12,000

2016: Intercultural Pedagogy Grant (IPG)

Purdue University International Programs

$3,000

2015: Project IMPACT Faculty Fellow

Purdue University Provost / ITAP

$10,000

2006: “Development of Nuclear Pharmacy Clerkship in the United Kingdom”.

Purdue University International Programs

$7,000

2005: “Employing Portable Video Technology as an Aid to Nuclear Pharmacy Laboratory

Instruction”.

Purdue University School of Pharmacy:

$15,000

GRANT SUPPORT: EXTERNAL

2017: “NorthStar Medical LIFT program”

NorthStar Medical Radioisotopes

$20,000 (equipment support at end of project)

2016 – 2017 “Evaluation of Tevadaptor in Radiology Applications”

Teva Pharmaceuticals

$58,277

2015 – 2017 “Evaluation of a Closed System Compounding Device for Radiopharmacy / Radiology Applications”

Teva Pharmaceuticals

$125,000

2015 – 2016 “Participation in a Human Factor Evaluation of the NorthStar TechneGen Instrument”

Brookhaven National Laboratory

$11,000

2012 – current “Cardinal Health Education Grant for Nuclear Pharmacy Programs”

$10,000 (annual renewal)

2011: “Training Program Partnership with Cardinal Health”

Cardinal Health

$11,000

2007 – 2011: “Extended Use and Sterility Study of Common Radiopharmaceuticals”

United Pharmacy Partners, Incorporated.

$36,500

2006 – 2012: “Cardinal Health Fellowship”

Cardinal Health Foundation

$25,000

PUBLICATIONS

Peer-reviewed publications

1. Pigmon S, Weatherman K, Brehl N, Neilsen C. The necessity of using heparin in an UltraTag RBC kit when tagging blood for a nuclear medicine study. J Nucl Med Technol. 2016 December;44(4):230-233.

2. Weatherman K, Augustine S, Christoff J, Galbraith W. Assessing the stability of common radiopharmaceuticals compounded and utilized outside of package insert guidelines. Int J Pharm Compd. 2013 May-Jun;17(3):238-246.

3. Weatherman K, Augustine S, Christoff J, Galbraith W. Establishing benchmark rates of microbial and bacterial endotoxin contamination for radiopharmaceuticals compounded in commercial nuclear pharmacy settings. Int J Pharm Compd. 2013 Mar-Apr;17(2):168-174.

4. Duncan, K. Radiopharmaceuticals for PET Imaging. J Nucl Med Technol 1998; 26:228-234.

5. Duncan, K. A Comparison of Tc-99m Labeled Radiopharmaceuticals for Imaging of the Central Nervous System. University of New Mexico, Continuing Education Series, Volume 4Lesson 3. 1995.

6. Park, H.M., and Duncan, K. Nonradioactive Pharmaceuticals in Nuclear Medicine. J Nucl MedTechnol 1994;22:240-249.

Books Edited

1. Kowalsky R, Weatherman K (eds). Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine 4th edition. Washington DC. American Pharmacists Association (in progress – 2018 publication)

2. Smith B, Weatherman K (eds). A Pharmacist’s Guide to Diagnostic Imaging. Washington DC. American Pharmacists Association. 2012

Book Chapters

1. Weatherman K. (2018). Diagnostic Imaging, Nuclear Medicine and Nuclear Pharmacy. In: Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine 4th Edition. Kowalsky R, Weatherman K (eds). Washington DC. American Pharmacists Association.

2. Weatherman K. (2018). Radionuclide Production. In: Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine 4th Edition. Kowalsky R, Weatherman K (eds). Washington DC. American Pharmacists Association.

3. Weatherman K. (2018). Radiation Detection and Instrumentation. In: Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine 4th Edition. Kowalsky R, Weatherman K (eds). Washington DC. American Pharmacists Association.

4. Weatherman K. (2018). Lung. In: Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine 4th Edition. Kowalsky R, Weatherman K (eds). Washington DC. American Pharmacists Association.

5. Richard M, Weatherman K. (2012). Regulations Associated with the Use of Ionizing Radiation. In: A Pharmacist’s Guide to Diagnostic Imaging. Smith B, Weatherman K (eds). Washington

DC. American Pharmacists Association.

6. Weatherman K. (2012). Radiopharmaceuticals Used in Positron Emission Tomography (PET) Imaging. In: A Pharmacist’s Guide to Diagnostic Imaging. Smith B, Weatherman K (eds).

Washington DC. American Pharmacists Association.

7. Weatherman K. (2012). Diagnostic Imaging and the Role of the Pharmacist. In: A Pharmacist’s Guide to Diagnostic Imaging. Smith B, Weatherman K (eds). Washington DC.

American Pharmacists Association.

8. Weatherman K. (2011) Clinical Primer for Radiopharmacists. In: Handbook of

Radiopharmacy. Cole C, Shaw S (eds). Washington DC. American Pharmacists Association.

9. Crisp W, Weber H, Weatherman K. (2010). The Physiologic Basis of Radiopharmaceuticals. In: Smith B Nuclear Pharmacy: Concepts and Applications in Nuclear Pharmacy. London:

Pharmaceutical Press.

10. Weatherman K. (2010). The Basics of Nuclear Pharmacy Practice: In: Smith B. Nuclear Pharmacy: Concepts and Applications in Nuclear Pharmacy. London: Pharmaceutical Press.

11. Weatherman K. (2010). Radiopharmacy Operations: In: Smith B. Nuclear Pharmacy:

Concepts and Applications in Nuclear Pharmacy. London: Pharmaceutical Press.

12. Weatherman K. (2010) Specialty Pharmacy Practice: In: Bachenheimer, B. Manual for Pharmacy Technicians, 4th Edition.

RESEARCH PRESENTED (PODIUM SELECTION)

1. Weidle J, Weatherman K. “Evaluating product stability and the potential for blood and radioactive contamination when using a closed system adaptor for the preparation of radiolabeled red blood cells” (podium presentation). Society of Nuclear Medicine Annual Meeting, Denver, Colorado. June 2017.

2. Weatherman K, Buhrmester D. “Establishing a relationship between temperature profiles and radiochemical purity when preparing Tc-99m sestamibi to determine optimal heating time for preparation” (podium presentation). Society of Nuclear Medicine Annual Meeting, San Diego, California. June, 2016

3. Weatherman, K, Augustine S, Christoff J, Galbraith W. “Evaluation of the microbial contamination rate of compounded radiopharmaceuticals prepared in commercial nuclear pharmacy settings” (podium presentation). Society of Nuclear Medicine Annual Meeting, New Orleans, Louisiana. June, 2008.

POSTERS PRESENTED

1. Weatherman K, Weidle J. “Evaluating product stability and contamination incidence when using a closed-system adaptor for the preparation of Tc-99m radiolabeled red blood cells”. American Pharmacists Association Annual Meeting, Nashville, Tennessee. March 2018.

2. Hakimian M, Weatherman K. “Evaluating the feasibility of a virtual reality training simulation for nuclear pharmacy radiation safety applications”. American Pharmacists Association Annual Meeting, Nashville, Tennessee. March 2018.

3. Weatherman K, DeAngelo V, Woods K, Yeboah K. “Evaluation of the utility of a closed system adapter in the preparation and dispensing of Tc-99m labeled radiopharmaceuticals. Society of Nuclear Medicine Annual Meeting, San Diego, California. June, 2016

4. Weatherman K, Luther J, Andrews K, Jacobs K. “Validation of radiochemical purity results obtained using new, commercially available ITLC-SG strips for Tc-99m based radiopharmaceuticals. American Pharmacists Association Annual Meeting. Seattle,

Washington. March 2011.

5. Weatherman K, Randolph M, Loveless V, Mayes J. “Evaluating the microbial contamination rate of Tc-99m labeled red blood cells compounded using a commercially available kit formulation when prepared under USP immediate use guidelines. American

Pharmacists Association Annual Meeting. Washington DC. March, 2010.

6. Weatherman K, Augustine S, Christoff J, Galbraith W. “Assessing Stability of Various Radiopharmaceutical Kits Compounded Outside of Package Insert Recommendations”

American Pharmacists Association Annual Meeting. Washington, DC. March, 2010

7. Weatherman K, Augustine S, Christoff J, Galbraith W, Pesce M. “Assessing Stability of Tc-99m Sestamibi and Tc-99m Mebrofenin when Compounded Outside of Package Insert Recommendations”. American Pharmacists Association Annual Meeting. San Antonio, Texas.

April, 2009

8. Weatherman K, Augustine S, Christoff J, Galbraith W. “Evaluating Microbial Contamination Rates of Radiopharmaceuticals Compounded in a Commercial Nuclear Pharmacy Setting”.

American Pharmacists Association Annual Meeting. San Antonio, Texas. April, 2009

9. Weatherman K. “Assessing the Utility of Video iPods in a Nuclear Pharmacy Laboratory Course”. International Pharmaceutical Federation World Congress. Beijing, China. August,

2007.

10. Duncan Weatherman K, Larimore, K. “The Effects of Additional Ascorbic Acid on the Stability of Tc-99m HDP”. American Pharmacist Association Annual Meeting. Atlanta, Georgia. March,

2007.

11. Fat Anthony, W, Kazmierczak, R, Duncan Weatherman K. “Pharmacist Evaluation of Cardiac Medication Profiles in Patients Presenting for Nuclear Medicine Myocardial Stress Testing”.

American Pharmacist Association Annual Meeting. Atlanta, Georgia. March, 2007.

12. Duncan K, Shaw S. “Nuclear Pharmacy – A Historical Perspective” American Pharmaceutical Association Annual Meeting, Philadelphia, Pennsylvania. March, 2002.

INVITED PRESENTATIONS

1. “Traumatic brain Injury Imaging”. United Pharmacy Partners Annual Meeting, Sarasota, FL. September 2017.

2. “Pharmacist Providers Guide to Nuclear Medicine and Molecular Imaging”. American Pharmacists Association Annual Meeting, San Francisco, CA. March, 2017.

3. “Continuing Education and the Purdue Nuclear Pharmacy Continuing Education Program”. United Pharmacy Partners Annual Meeting, Scottsdale, AZ. September 2016.

4. “Alternate Sources of Technetium”. Central Chapter Meeting – Society of Nuclear Medicine and Molecular Imaging. Indianapolis, Indiana. October, 2015

5. “Compounding vs. Manufacturing – A Review of Current Status”. Florida Pharmacists Association Mid Year Clinical Meeting, Orlando, Florida. October, 2015.

6. “Pharmacovigilance and Adverse Event Reporting”. United Pharmacy Partners Annual Meeting. Sarasota, FL. September, 2015

7. “Compounding vs. Manufacturing: What Does It All Mean?” Mallinckrodt Pharmaceuticals User Breakfast – 2014 Society of Nuclear Medicine and Molecular Imaging Annual Meeting, St. Louis, MO. June, 2014

8. “Clinical Problem Solving in Nuclear Medicine”. Florida Pharmacists Association Mid Year Clinical Meeting, Orlando, Florida. October 2013.

9. “Radium 223 for Castration Resistant Prostate Cancer”. Florida Pharmacists Association Mid Year Clinical Meeting, Orlando, Florida. October 2013.

10. “What to Do with Adverse Reactions: A Lexiscan Case Study”. Florida Pharmacists Association Mid Year Clinical Meeting, Orlando, Florida. October 2012.

11. “Radiobiology Review”. Florida Pharmacists Association Mid Year Clinical Meeting, Orlando, Florida. October 2012.

12. “A Review of Pharmaceuticals Used in Diagnostic Imaging”. Charities and Maladies Continuing Education Series. Ft Myers, Florida. June 2012.

13. “Update on Drug-Radiopharmaceutical and Contrast Media – Radiopharmaceutical Interactions”. Florida Pharmacists Association Mid Year Clinical Meeting. Orlando, Florida.

October, 2011.

14. “Joint Commission Standards and Guidelines and Their Impact on Nuclear Medicine / Radiology”. Florida Pharmacists Association Mid Year Clinical Meeting. Orlando, Florida.

October, 2011.

15. “Precautions for Administration of Non-Radioactive Drugs in Nuclear Medicine – Renal, Biliary, Thyroid, Brain Imaging”. Indiana University School of Medicine, Department of Radiology.

October, 2010.

16. “Precautions for Administration of Non-Radioactive Drugs in Nuclear Medicine – Cardiac

Imaging”. Indiana University School of Medicine, Department of Radiology. October, 2010

17. “Adverse Reactions to Medication and Contrast Media on Nuclear Medicine Exams”. Missouri Valley / Central Chapter of the Society of Nuclear Medicine Joint Fall meeting. St. Louis,

Missouri. October, 2010

18. “Basics of Nuclear Pharmacy Education and Training” Seminar 5 – Radiopharmacy. Twentieth

Congress of the Pan American Pharmacy. Porto Alegre, Brazil. May, 2010

19. “Cardiac Stress Pharmaceuticals”. Central Chapter of the Society of Nuclear Medicine Spring

Meeting. Ft Wayne, Indiana. March, 2010

20. “A Review of Radiopharmaceuticals Used in Infection and Inflammation Imaging”. Florida

Pharmacists Association. Orlando, Florida. October, 2009

21. “Clinical Uses of Radiopharmaceuticals”. International Pharmaceutical Federation Annual

Meeting, Istanbul, Turkey. September, 2009

22. “Medication Management in Nuclear Pharmacy”. American Pharmacists Association Annual

Meeting, San Antonio, Texas. April, 2009.

23. “USP and Nuclear Medicine”. Central Ohio Society of Nuclear Medicine Technologist

Annual Meeting, Columbus, Ohio. October, 2008.

24. “Non-radioactive Pharmaceuticals in Nuclear Medicine”. Indiana University Department of

Radiologic Technology In-service, Indianapolis, Indiana. October, 2008.

25. Patient Safety Considerations of Medications Used in Imaging”. Central Chapter of the Society

of Nuclear medicine Annual Spring Meeting. Milwaukee, Wisconsin. March, 2008.

26. “A Radiopharmaceutical Quality Control Manual”. International Pharmaceutical Federation

Annual Meeting, Beijing, China. September, 2007.

27. “USP and Its Impact on Nuclear Pharmacy and Nuclear Medicine Departments”.

Heartlight Pharmacy Continuing Education Series, Lima, Ohio. May, 2008.

28. “Non-radioactive Drugs and their effects on Nuclear Medicine Studies”. Indiana University Nuclear Medicine Technology Applications of Radionuclides II (RADI R433), Indianapolis,

Indiana. October 2006.

29. “Adverse Drug Reactions and The Immune System – A Review”. Florida Pharmaceutical

Association, Orlando, Florida. October, 2006.

30. “Nuclear Medicine vs. Other Imaging Modalities”. Florida Pharmaceutical Association, Orlando,

Florida. October, 2006.

31. “Quality Control”. International Pharmaceutical Federation Annual Meeting, Salvador Bahia,

Brazil. August, 2006.

32. “Clinical Nuclear Pharmacy”. International Pharmaceutical Federation Annual Meeting,

Salvador Bahia, Brazil. August, 2006

33. “Centralized Nuclear Pharmacy Practice”. International Pharmaceutical Federation Annual

Meeting, Salvador Bahia, Brazil. August, 2006.

34. “Nuclear Pharmacy Technicians – What Do They Do?” National Pharmacy Technicians

Association Annual Meeting, Las Vegas, Nevada. July, 2006.

35. “Nuclear Pharmacy Issues for Aseptic Compounding in Isolators and Application of USP 797”.

Cleanroom Conference, Boston, Massachusetts. March, 2006.

36. “A Review of Hepatitis (A, B and C). Florida Pharmaceutical Association, Orlando, Florida.

October, 2005.

37. “Drug Utilization Review for Nuclear Pharmacists – Where Do We Fit?” Florida Pharmaceutical

Association, Orlando, Florida. October 2005.

38. “Nuclear Pharmacy Technicians”. National Pharmacy Technician Association Annual Meeting,

New Orleans, Louisiana. July, 2005.

39. “Pediatric Nuclear Medicine”. Florida Pharmaceutical Association, Orlando, Florida. October

2004.

40. “Nuclear Medicine Considerations with Pregnancy and Breastfeeding”. Florida Pharmaceutical

Association. Orlando, Florida. October, 2004.

41. “Herbal Medicines and Nuclear Pharmacy – an Update”. Florida Pharmaceutical Association

Orlando, Florida. October 2003.

42. “Understanding the “HOT” Topic of Nuclear Pharmacy – A Technician’s Perspective”. National

Pharmacy Technician Association Annual Meeting, Las Vegas, Nevada. June, 2003.

43. “Herbal Medications and Nuclear Pharmacy”. Florida Pharmaceutical Association, Orlando,

Florida. October 2002.

44. “Herbal Medicines in Nuclear Medicine – An “Unclear” Problem. Grand Rapids Technologist

Meeting, Grand Rapids, Michigan. February 2002.

45. “Advances in Radiopharmaceuticals”. Society of Nuclear Medicine India Millennium

Conference, Mumbai, India. November, 2000

46. “Nonradioactive Pharmaceuticals Used In Nuclear Medicine”. Florida Pharmaceutical

Association, Orlando, Florida. October, 2000.

47. “What’s New in Radiopharmaceuticals - Bone Pain Palliation”. American Pharmaceutical

Association Annual Meeting. Miami Beach, Florida. March, 1998.

WEBINAR RECORDING

1. “Best Practices for Contrast Agent Use: Implications for Clinical Pharmacists. Contrast Agents 101”. MedXcel, LLC. Tampa Florida. 2011. Available at

ACADEMIC COLLABORATIONS

2015 – present St. Bartholomew’s Hospital and The Royal London Hospital Trust

• PharmD. Clerkship focusing on cardiac and oncology practice in the United Kingdom

2007 – present St. Bartholomew’s Hospital and The Royal London Hospital Trust

• PharmD. clerkship focusing on nuclear pharmacy compounding in aseptic

Conditions

2002 – 2005 Co-founder - VirRAD: Virtual Learning Community in Radiopharmacy

• European intiative for developing on-line training for radiopharmacists

1998 – 2014 Indiana University Medical Center – Department of Nuclear Medicine

• PharmD. clerkship in nuclear medicine

CERTIFICATION PROGRAMS

2004 – 2010 Nuclear Pharmacist Clinical Refresher Course

- 20 students trained annually

2003 – current Nuclear Pharmacy Technician Training Program

- 15 students trained annually

2000 – current Nuclear Pharmacy Certificate Program

- 30 students trained annually

CONTINUING EDUCATION PROGRAMS

2018 – present Nuclear Medicine Technologist Continuing Education Program / Educational Portal

- Society of Nuclear Medicine VOICE approved provider of continuing education for nuclear medicine technologists

2016 - present Nuclear Pharmacist Continuing Education Program / Educational Portal

- ACPE approved provider of continuing education for pharmacists

- BPS approved provider of BCNP recertification continuing education for pharmacists

2016 - present Nuclear Pharmacy Technician Continuing Education Program / Educational Portal

- ACPE approved provider of continuing education for pharmacy technicians

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download